Loading...
Arkema S.A.
AKE.PA•EURONEXT
Basic MaterialsChemicals - Specialty
€60.30
€-0.55(-0.90%)
Arkema S.A. (AKE.PA) Financial Performance & Statements
Review Arkema S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.32%
↑ 0.32%
Operating Income Growth
-13.95%
↓ 13.95%
Net Income Growth
-11.94%
↓ 11.94%
Operating Cash Flow Growth
-10.75%
↓ 10.75%
Operating Margin
6.89%
↑ 6.89%
Gross Margin
20.32%
↑ 20.32%
Net Profit Margin
3.71%
↑ 3.71%
ROE
5.00%
↑ 5.00%
ROIC
5.17%
↑ 5.17%
Arkema S.A. (AKE.PA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Arkema S.A. stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $2.27B | $2.39B | $2.54B | $2.34B |
Cost of Revenue | $1.85B | $1.92B | $1.97B | $1.87B |
Gross Profit | $423.00M | $477.00M | $571.00M | $468.00M |
Gross Profit Ratio | $0.19 | $0.20 | $0.23 | $0.20 |
R&D Expenses | $94.00M | $47.00M | $68.00M | $69.00M |
SG&A Expenses | $225.00M | $222.00M | $238.00M | $235.00M |
Operating Expenses | $373.00M | $269.00M | $306.00M | $2.18B |
Total Costs & Expenses | $2.22B | $2.19B | $2.27B | $2.18B |
Interest Income | $0.00 | $0.00 | $3.00M | $0.00 |
Interest Expense | $0.00 | $20.00M | $15.00M | $0.00 |
Depreciation & Amortization | $187.00M | $200.00M | $186.00M | $186.00M |
EBITDA | $87.00M | $408.00M | $451.00M | $350.00M |
EBITDA Ratio | $0.04 | $0.17 | $0.18 | $0.15 |
Operating Income | $50.00M | $208.00M | $265.00M | $135.00M |
Operating Income Ratio | $0.02 | $0.09 | $0.10 | $0.06 |
Other Income/Expenses (Net) | -$22.00M | -$44.00M | -$64.00M | -$19.00M |
Income Before Tax | $28.00M | $164.00M | $202.00M | $116.00M |
Income Before Tax Ratio | $0.01 | $0.07 | $0.08 | $0.05 |
Income Tax Expense | $20.00M | $42.00M | $52.00M | $36.00M |
Net Income | $12.00M | $118.00M | $145.00M | $79.00M |
Net Income Ratio | $0.005 | $0.05 | $0.06 | $0.03 |
EPS | $0.16 | $1.43 | $1.94 | $0.99 |
Diluted EPS | $0.16 | $1.43 | $1.93 | $0.99 |
Weighted Avg Shares Outstanding | $75.80M | $82.52M | $74.68M | $74.80M |
Weighted Avg Shares Outstanding (Diluted) | $75.80M | $82.52M | $75.04M | $75.04M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan